Skip to main content
Aker BioMarine logo

Aker BioMarine — Investor Relations & Filings

Ticker · AKBM ISIN · NO0010886625 LEI · 549300V34T6VWDSYWE64 OL Agriculture, forestry and fishing
Open in API
Filings indexed 508 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country NO Norway
Listing OL AKBM

About Aker BioMarine

https://www.akerbiomarine.com/

Aker BioMarine is a biotechnology innovator that sustainably harvests Antarctic krill to develop and supply krill-derived ingredients. The company's core business focuses on producing ingredients for the human health and nutrition markets, including nutraceuticals and dietary supplements. It also serves the aquaculture and animal feed sectors with specialized products. Aker BioMarine leverages its vertically integrated supply chain and scientific research to create a portfolio of products that extends to agricultural biostimulants and pharmaceutical applications. The company is committed to sustainable operations and the scientific validation of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Aker BioMarine wins new Lysoveta contract
Regulatory Filings Classification · 95% confidence The document is a short announcement about Aker BioMarine securing a new contract for the supply of Lysoveta, including contract value and product details. It contains no financial statements, no detailed financial performance data, no regulatory filings, no voting results, no management or board changes, and no mention of report attachments or certifications. The document is a commercial contract update and does not fit into categories like Annual Report, Earnings Release, or Capital Update. It is a general regulatory announcement about a business development, which fits best under Regulatory Filings (RNS) as a miscellaneous announcement that does not fit other specific categories. The document length is short (2175 characters), and it is not a report publication announcement or certification.
2026-05-06 Norwegian
First quarter 2026 results for Aker BioMarine - Attachment: AKBM_Q1_2026_Presentation_PUBLISH.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Q1 2026' and contains detailed financial data including revenues, EBITDA, profit and loss statements, balance sheet, cash flow, segment commentary, and outlook. It covers a quarterly period (Q1 2026) and includes unaudited financial figures compared to prior periods. The document is about 15,000 characters long, which is substantial and contains actual financial statements and analysis, not just an announcement or summary. It is clearly a comprehensive quarterly financial report rather than a brief earnings release or a regulatory filing. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-30 English
First quarter 2026 results for Aker BioMarine
Interim / Quarterly Report Classification · 95% confidence The document is titled 'First quarter 2026 results for Aker BioMarine' and contains detailed financial performance data for the first quarter of 2026, including revenues, EBITDA, segment performance, and outlook. It also mentions a webcast and provides contact information for investor relations. The content is a comprehensive financial report for a period shorter than a full fiscal year, with substantive financial data and analysis. The document length is 4230 characters, which is sufficient to contain actual financial data rather than just an announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-30 English
Aker BioMarine ASA: Minutes of Annual General Meeting - Attachment: AGM Minutes Aker BioMarine ASA 28 April 2026.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is clearly the official minutes (protocol) of the Annual General Meeting of Aker BioMarine ASA held on 28 April 2026. It records the agenda items, resolutions passed, and voting results for each matter. According to the filing definitions, this falls under “Declaration of Voting Results & Voting Rights Announcements” (DVA), which covers official results from shareholder votes at any general meeting (AGM or EGM). This is not a simple presentation or investor deck (AGM-R), nor a solicitation or proxy statement (PSI), but the formal record of voting outcomes and decisions made at the AGM.
2026-04-28 Norwegian
Aker BioMarine ASA: Minutes of Annual General Meeting
AGM Information Classification · 75% confidence The document is the official minutes of the 2026 Annual General Meeting, detailing resolutions and board elections and noting that the minutes are available. It is not a standalone earnings report or regulatory fallback but specific AGM materials. This matches the AGM Information category.
2026-04-28 English
Aker BioMarine ASA – Invitation to presentation of the first quarter 2026 results
Report Publication Announcement Classification · 85% confidence The document is a brief invitation announcing the date and format of the upcoming first quarter 2026 results release and webcast presentation. It does not contain the actual financial results or detailed presentation materials. It serves solely to notify investors of the timing and access details for the report presentation. Under the “Menu vs Meal” rule, this is an announcement of an upcoming report and webcast, classifying it as a Report Publication Announcement (RPA).
2026-04-27 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.